In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nanotherapeutics Inc.

www.nanotherapeutics.com

Latest From Nanotherapeutics Inc.

Execs On The Move, July 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Pfizer To Take Zinplava Rival Into Phase III For C Diff

Pfizer will start a Phase III trial for its Clostridium difficile vaccine by the middle of the year, taking aim at the chinks in the armour of Merck & Co’s recently approved Zinplava, but it still trails its rival from Sanofi.

Infectious Diseases Vaccines

Execs On The Move, January 2017

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

BioPharmaceutical Medical Device

Just The Tonix: New York Biotech Has Breakthrough Drug For PTSD

Tonix Pharmaceuticals has won a breakthrough therapy designation this month for its post-traumatic stress disorder drug – the most advanced product in development specifically for the condition and potentially the first ever to market targeting PTSD as its lead indication.

Business Strategies Research & Development
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
    • Large Molecule
    • Nanotechnology, Chips, etc.
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
      • Nasal
      • Pulmonary
      • Topical Delivery
    • Vaccines
  • Services
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nanotherapeutics Inc.
  • Senior Management
  • Peter Khoury, PhD, Pres. & CEO
    James M Matthew, CFO
    Gary A Asconi, VP, Bus. Dev.
    Ron Cobb, PhD, CSO
  • Contact Info
  • Nanotherapeutics Inc.
    Phone: (386) 462-9663
    13200 NW Nano Ct.
    Alachula, FL 32615
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register